Etiology and Pharmacology of Neuropathic Pain
Top Cited Papers
Open Access
- 2 March 2018
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Pharmacological Reviews
- Vol. 70 (2), 315-347
- https://doi.org/10.1124/pr.117.014399
Abstract
Injury to or disease of the nervous system can invoke chronic and sometimes intractable neuropathic pain. Many parallel, interdependent, and time-dependent processes, including neuroimmune interactions at the peripheral, supraspinal, and spinal levels, contribute to the etiology of this “disease of pain.” Recent work emphasizes the roles of colony-stimulating factor 1, ATP, and brain-derived neurotrophic factor. Excitatory processes are enhanced, and inhibitory processes are attenuated in the spinal dorsal horn and throughout the somatosensory system. This leads to central sensitization and aberrant processing such that tactile and innocuous thermal information is perceived as pain (allodynia). Processes involved in the onset of neuropathic pain differ from those involved in its long-term maintenance. Opioids display limited effectiveness, and less than 35% of patients derive meaningful benefit from other therapeutic approaches. We thus review promising therapeutic targets that have emerged over the last 20 years, including Na+, K+, Ca2+, hyperpolarization-activated cyclic nucleotide–gated channels, transient receptor potential channel type V1 channels, and adenosine A3 receptors. Despite this progress, the gabapentinoids retain their status as first-line treatments, yet their mechanism of action is poorly understood. We outline recent progress in understanding the etiology of neuropathic pain and show how this has provided insights into the cellular actions of pregabalin and gabapentin. Interactions of gabapentinoids with the α2δ-1 subunit of voltage-gated Ca2+ channels produce multiple and neuron type-specific actions in spinal cord and higher centers. We suggest that drugs that affect multiple processes, rather than a single specific target, show the greatest promise for future therapeutic development.This publication has 459 references indexed in Scilit:
- A role for Piezo2 in EPAC1-dependent mechanical allodyniaNature Communications, 2013
- Peripheral Nerve Injury is Accompanied by Chronic Transcriptome-Wide Changes in the Mouse Prefrontal CortexMolecular Pain, 2013
- Angiotensin II type 2 receptor (AT2R) localization and antagonist‐mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neuronsEuropean journal of pain, 2012
- CCL2 promotes P2X4 receptor trafficking to the cell surface of microgliaPurinergic Signalling, 2012
- Hyperalgesia by synaptic long-term potentiation (LTP): an updateCurrent Opinion in Pharmacology, 2011
- Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up studyThe Journal of Headache and Pain, 2011
- Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS SynaptogenesisCell, 2009
- Cellular and Molecular Mechanisms of PainCell, 2009
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural PlasticityThe Journal of Pain, 2009
- Hyperpolarization-activated current (Ih) contributes to excitability of primary sensory neurons in ratsBrain Research, 2008